Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
---|
CEO | Dr. Allan John Syms |
IPO Date | May 14, 2021 |
Location | United Kingdom |
Headquarters | 60 Gracechurch Street |
Employees | 4 |
Sector | Healthcare |
Industries |
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Past 5 years
USD 0.06
StockViz Staff
February 4, 2025
Any question? Send us an email